# EDGAR Filing Document

**Accession Number:** 0001944552
**File Stem:** 0001213900-26-047443
**Filing Date:** 2026-4
**Character Count:** 1869
**Document Hash:** df68429203fa0f800f22b9e9317ef6d6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-047443.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0001213900-26-047443

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260424

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Adlai Nortye Ltd.
- **CENTRAL INDEX KEY:** 0001944552
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 685 U.S. HIGHWAY ONE, 2ND FLOOR
- **CITY:** NORTH BRUNSWICK
- **STATE:** NJ
- **ZIP:** 08902
- **BUSINESS PHONE:** 848-230-7430

**MAIL ADDRESS:**
- **STREET 1:** 685 U.S. HIGHWAY ONE, 2ND FLOOR
- **CITY:** NORTH BRUNSWICK
- **STATE:** NJ
- **ZIP:** 08902

**Adlai Nortye Ltd.**

c/o PO Box 309

Ugland House

Grand Cayman KY1-1104

Cayman Islands

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, D.C., 20549

April 24, 2026

---

| | |
|:---|:---|
| **Re:** | **Adlai Nortye Ltd.** |
|  | **Registration Statement on Form F-3, as amended** |
|  | **Initially Filed March 10, 2026** |
|  | **File No. 333-294173** |

---

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Adlai Nortye Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement on Form F-3, as amended, so that it will become effective at 9:30 a.m. ET April 28, 2026, or as soon as thereafter practicable.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| /s/ Yang Lu | /s/ Yang Lu |
| Name: | Yang Lu |
| Title: | Chief Executive Officer and Chairman of Board of Directors |

---